These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1324986)

  • 21. Success and failure at outpatient opioid detoxification. Evaluating the process of clonidine- and methadone-assisted withdrawal.
    Rounsaville BJ; Kosten T; Kleber H
    J Nerv Ment Dis; 1985 Feb; 173(2):103-10. PubMed ID: 3881558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial.
    Ahmadi-Abhari SA; Akhondzadeh S; Assadi SM; Shabestari OL; Farzanehgan ZM; Kamlipour A
    J Clin Pharm Ther; 2001 Feb; 26(1):67-71. PubMed ID: 11286609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative strategies of opiate detoxification: evaluation of the so-called ultra-rapid detoxification.
    Scherbaum N; Klein S; Kaube H; Kienbaum P; Peters J; Gastpar M
    Pharmacopsychiatry; 1998 Nov; 31(6):205-9. PubMed ID: 9930633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opiate withdrawal symptoms in response to 10-day and 21-day methadone withdrawal programmes.
    Gossop M; Griffiths P; Bradley B; Strang J
    Br J Psychiatry; 1989 Mar; 154():360-3. PubMed ID: 2688778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opiate withdrawal.
    Farrell M
    Addiction; 1994 Nov; 89(11):1471-5. PubMed ID: 7841858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal Scale.
    Rosse RB; Johri S; Goel M; Rahman F; Jawor KA; Deutsch SI
    Clin Neuropharmacol; 1998; 21(5):312-5. PubMed ID: 9789712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification.
    Gossop M; Strang J
    Br J Psychiatry; 1991 May; 158():697-9. PubMed ID: 1860023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Static and dynamic pupillometry for determination of the course of gradual detoxification of opiate-addicted patients.
    Grünberger J; Linzmayer L; Fodor G; Presslich O; Praitner M; Loimer N
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(2):109-12. PubMed ID: 2149649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.
    Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 1998 May; 50(3):227-32. PubMed ID: 9649976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Auricular acupuncture as an adjunct to opiate detoxification treatment: effects on withdrawal symptoms.
    Bearn J; Swami A; Stewart D; Atnas C; Giotto L; Gossop M
    J Subst Abuse Treat; 2009 Apr; 36(3):345-9. PubMed ID: 19004596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts.
    Kosten TR; Rounsaville BJ; Kleber HD
    Am J Drug Alcohol Abuse; 1985; 11(1-2):1-10. PubMed ID: 3904410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
    Gold MS
    Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical use of clonidine in outpatient detoxification from opiates.
    Washton AM; Resnick RB
    Prog Clin Biol Res; 1981; 71():277-84. PubMed ID: 7330080
    [No Abstract]   [Full Text] [Related]  

  • 35. Importance of gabapentin dose in treatment of opioid withdrawal.
    Salehi M; Kheirabadi GR; Maracy MR; Ranjkesh M
    J Clin Psychopharmacol; 2011 Oct; 31(5):593-6. PubMed ID: 21869694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance.
    Stine SM; Kosten TR
    Am J Drug Alcohol Abuse; 1994 Nov; 20(4):445-58. PubMed ID: 7832179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organic mood syndrome associated with detoxification from methadone maintenance.
    Kanof PD; Aronson MJ; Ness R
    Am J Psychiatry; 1993 Mar; 150(3):423-8. PubMed ID: 8434657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study.
    Uhde TW; Redmond DE; Kleber HD
    Psychiatry Res; 1980 Mar; 2(1):37-47. PubMed ID: 6932053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
    Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
    JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of very low-dose naltrexone during opiate detoxification.
    Mannelli P; Gottheil E; Buonanno A; De Risio S
    J Addict Dis; 2003; 22(2):63-70. PubMed ID: 12703669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.